Recipharm

From Wikipedia, the free encyclopedia

Template:Short description

Page Module:Message box/ambox.css has no content.

Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.

Recipharm AB
FormerlyRecip
ISINScript error: No such module "WikidataIB".
IndustryScript error: No such module "WikidataIB".
PredecessorScript error: No such module "WikidataIB".
IncorporatedScript error: No such module "WikidataIB".
FoundedScript error: No such module "WikidataIB".
FounderScript error: No such module "WikidataIB".
DefunctScript error: No such module "WikidataIB".
SuccessorScript error: No such module "WikidataIB".
Headquarters
Stockholm, Sweden
Key people
Richard Ridinger, Chairman, Greg Behar, CEO, Rodolfo J. Savitzky, CFO
ProductsPharmaceutical products for humans
RevenueScript error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Total assetsScript error: No such module "WikidataIB".
Number of employees
Script error: No such module "WikidataIB".
ParentScript error: No such module "WikidataIB".
Websiterecipharm.com

Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".

Recipharm is a leading global Contract Development and Manufacturing Organisation (CDMO), employing 5,200 people and operating in over a hundred markets worldwide.

Recipharm offers pharmaceutical manufacturing services across various dosage forms, including sterile fill & finish, oral solid dosage, and biologics. Additionally, they provide clinical trial material development and manufacturing services, as well as pharmaceutical product development.

Recipharm manufactures several hundred different products for customers ranging from large pharmaceutical companies to smaller research and development firms.

History

Recip 1995-2007

In March 1995, Thomas Eldered and Lars Backsell conducted a management buyout of a Pharmacia solid dose tablet manufacturing facility in Årsta, Stockholm and formed the company Recip. The facility had 130 employees and a turnover of SEK 220 million.[1] The company continued to manufacture pharmaceutical products for Pharmacia during a transition period while it also developed its own products. Recip also began providing contract manufacturing services to other pharmaceutical companies.

In 1997, Recip was believed to be the first pharmaceutical company in the world to certify its entire operations according to the ISO 14001 environmental management system.[2] From 1998, the company began to grow by acquiring facilities in Sweden. The brand name Recipharm was established in 2001 for the growing contract manufacturing part of Recip's business. In 2007, the Recip part of the business and the company's own portfolio were divested to Meda.[3]

Recipharm 2007-present

Following the sale of Recip, the company focused on its contract manufacturing business. The capital from the sale of Recip was used to make further acquisitions – initially in Europe and later the US and India. Acquisitions were used to broaden the company's offering and customer base, and to enter new markets.

Recipharm became a public listed company on Nasdaq Stockholm in 2014.[4] Between 2014 and 2019, Recipharm's sales grew by an average of more than 30 per cent annually, including a combination of internal growth and acquisitions.[citation needed] In 2020, Recipharm completed its largest acquisition to date. The £505 million takeover of UK-based Consort Medical added around 2,000 employees and ten European facilities to the company, as well as new device capabilities.

In February 2021, Private equity firm EQT acquired Recipharm[5] for $2.1 billion. In March 2021, Mark Funk joined Recipharm as CEO, replacing Thomas Eldered who remains on the Board of Directors.[5] In 2022, Recipharm acquired CDMOs Arranta Bio, Vibalogics, and Genlbet to increase its biologics and virus manufacturing business. [6]

In January 2024, Greg Behar was appointed Chief Executive Officer at Recipharm, succeeding Mark Funk who remains on the Board of Directors.[7] In April 2024, Recipharm sold seven of their manufacturing sites to Blue Wolf Capital Partners and spun-out Bespak as a standalone drug delivery business.[8]

The Recipharm International Environmental Award

Recipharm's International Environmental Award was annually awarded for the best environmental performance or environmental innovation within the pharmaceutical industry or academia.[9] The final award, recognizing the 2020 winner, was presented in 2021.[10]

External Recognition

  • 2006 - Environmental Leadership award from the NMC Swedish Association for Sustainable business
  • 2012 - Ernst & Young ‘Entrepreneur of the Year prize’ for Best International growth was awarded to Thomas Eldered and Lars Backsell[11]
  • 2014 - The Royal Patriotic Society awarded Thomas Eldered and Lars Backsell with the Enterprise medal for outstanding entrepreneurship[12]
  • 2015 - The annual SwedenBIO Award was presented to Recipharm for their contribution to Sweden life science during the year[13]

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content."The Recipharm story". Recipharm. Archived from the original on 2016-08-16. Retrieved 17 March 2017 – via Internet Archive.
  2. ^ Page Module:Citation/CS1/styles.css has no content.Nyström, Anna (2 May 2005). "Läkemedelsföretag med miljöprofil" [Pharmaceutical company with an environmental profile]. Miljö & Utveckling (in svenska). Retrieved 10 September 2022.
  3. ^ Page Module:Citation/CS1/styles.css has no content."Meda acquires Recip" (PDF) (Press release). Meda AB. Retrieved 10 September 2022.
  4. ^ Page Module:Citation/CS1/styles.css has no content."Recipharm". Recipharm. 2014. Retrieved 17 March 2020 – via NASDAQ.
  5. ^ a b Page Module:Citation/CS1/styles.css has no content."Recipharm". Current Portfolio. EQT. 2021. Retrieved 10 September 2022.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Kansteiner, Fraiser (18 February 2022). "Recipharm, working on Moderna's COVID vaccine, boosts biologics presence with Arranta Bio, Vibalogics buyouts | Fierce Pharma". www.fiercepharma.com.
  7. ^ Page Module:Citation/CS1/styles.css has no content."Marc Funk to transition to Recipharm's Board of Directors; Greg Behar appointed new CEO; Inhaled Business to standalone in 2024".
  8. ^ Page Module:Citation/CS1/styles.css has no content.Dunleavy, Kevin (2 April 2024). "CDMO Recipharm sells 7 facilities in Europe to Blue Wolf Capital". www.fiercepharma.com.
  9. ^ Page Module:Citation/CS1/styles.css has no content."Recipharm International Environmental Award".
  10. ^ Page Module:Citation/CS1/styles.css has no content."Recipharm names 2020 International Environmental Award winner".
  11. ^ Page Module:Citation/CS1/styles.css has no content."Lars Backsell och Thomas Eldered, Recipharm, från Jordbro är två av Sveriges främsta entreprenörer". News Powered by Cision (in svenska). Retrieved 2020-03-17.
  12. ^ Page Module:Citation/CS1/styles.css has no content."Founders of Recipharm awarded enterprise medal". Nordic Life Science – the leading Nordic life science news service. 2014-04-11. Retrieved 2020-03-17.
  13. ^ Page Module:Citation/CS1/styles.css has no content."Recipharm AB: Recipharm wins SwedenBIO Award - Analysguiden". Aktiespararna (in svenska). 5 June 2015. Retrieved 2020-03-17.

Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.

Retrieved from "https://cosmopedia.co/index.php?title=Recipharm&oldid=7138981"